Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yang, Chengyan
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke	Recruiting	3	1380	RoW	Shuxuening Injection, Placebo	Beijing Tiantan Hospital	Ischemic Stroke, Acute	06/25	12/26
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke	Recruiting	3	1380	RoW	Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin	Beijing Tiantan Hospital	Ischemic Stroke, Acute	12/25	12/26
TREND-IVT, NCT06548971: Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke	Recruiting	3	1184	RoW	Aspirin, Placebo, Best medical management	Capital Medical University	Acute Ischemic Stroke, Cerebral Infarction	03/26	03/26
Wu, Mingchao
TREND-IVT, NCT06548971: Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke	Recruiting	3	1184	RoW	Aspirin, Placebo, Best medical management	Capital Medical University	Acute Ischemic Stroke, Cerebral Infarction	03/26	03/26